Denton, Christopher P.
Laird, Bee
Moros, Lizette
Flores, Jose Luis Luna
Funding for this research was provided by:
Boehringer Ingelheim (N/A)
Article History
Received: 20 December 2019
Revised: 13 March 2020
Accepted: 23 March 2020
First Online: 13 April 2020
Compliance with ethical standards
:
: C Denton reports grants and personal fees from GSK, personal fees from Boehringer Ingelheim, grants and personal fees from Inventiva, personal fees from Actelion, grants and personal fees from CSL Behring, personal fees from Bayer, personal fees from Roche, personal fees from Sanofi, during the conduct of the study. L Moros, and JL Luna Flores are employees of Boehringer Ingelheim. B Laird was a contractor to Boehringer Ingelheim at the time this research was conducted.
: The procedures followed in this study were in accordance with the Declaration of Helsinki. All participants provided written informed consent before taking part in the study, and all study data were held according to European Union (EU) data protection laws. The research outline was discussed with the Reading Independent Ethics Committee (UK), who advised that no ethics committee review was required. Additionally, and per the European Pharmaceutical Market Research Association (EphMRA) Code of Conduct 2019, this research was classified as market research and therefore does not require ethics committee approval (includes Brazil, Canada, Denmark, Finland, France, Germany, Greece, Italy, Japan, Mexico, theĀ Netherlands, Norway, Poland, Russia, South Korea, Spain, Sweden, Turkey, the UK and the USA).